HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multiple-clade H5N1 influenza split vaccine elicits broad cross protection against lethal influenza virus challenge in mice by intranasal vaccination.

AbstractBACKGROUND:
The increase in recent outbreaks and unpredictable changes of highly pathogenic avian influenza (HPAI) H5N1 in birds and humans highlights the urgent need to develop a cross-protective H5N1 vaccine. We here report our development of a multiple-clade H5N1 influenza vaccine tested for immunogenicity and efficacy to confer cross-protection in an animal model.
METHODOLOGY/PRINCIPAL FINDINGS:
Mice received two doses of influenza split vaccine with oil-in-water emulsion adjuvant SP01 by intranasal administration separated by two weeks. Single vaccines (3 µg HA per dose) included rg-A/Vietnam/1203/2004(Clade 1), rg-A/Indonesia/05/2005(Clade 2.1), and rg-A/Anhui/1/2005(Clade 2.3.4). The trivalent vaccine contained 1 µg HA per dose of each single vaccine. Importantly, complete cross-protection was observed in mice immunized using trivalent vaccine with oil-in-water emulsion adjuvant SP01 that was subsequently challenged with the lethal A/OT/SZ/097/03 influenza strain (Clade 0), whereas only the survival rate was up to 60% in single A/Anhui/1/2005 vaccine group.
CONCLUSION/SIGNIFICANCE:
Our findings demonstrated that the multiple-clade H5N1 influenza vaccine was able to elicit a cross-protective immune response to heterologous HPAI H5N1 virus, thus giving rise to a broadly cross-reactive vaccine to potential prevention use ahead of the strain-specific pandemic influenza vaccine in the event of an HPAI H5N1 influenza outbreak. Also, the multiple-clade adjuvanted vaccine could be useful in allowing timely initiation of vaccination against unknown pandemic virus.
AuthorsPenghui Yang, Yueqiang Duan, Peirui Zhang, Zhiwei Li, Cheng Wang, Mei Dong, Chong Tang, Li Xing, Hongjing Gu, Zhongpeng Zhao, Xiufan Liu, Shaogeng Zhang, Xiliang Wang
JournalPloS one (PLoS One) Vol. 7 Issue 1 Pg. e30252 ( 2012) ISSN: 1932-6203 [Electronic] United States
PMID22279575 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Viral
  • Immunoglobulin A
  • Influenza Vaccines
  • Interleukin-4
  • Interferon-gamma
Topics
  • Administration, Intranasal
  • Animals
  • Antibodies, Viral (blood, immunology)
  • Cross Protection (immunology)
  • Cross Reactions (immunology)
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Immunoglobulin A (blood, immunology)
  • Influenza A Virus, H5N1 Subtype (classification, immunology)
  • Influenza Vaccines (administration & dosage, immunology)
  • Interferon-gamma (immunology, metabolism)
  • Interleukin-4 (immunology, metabolism)
  • Lymphocytes (drug effects, immunology, metabolism)
  • Mice
  • Mice, Inbred BALB C
  • Orthomyxoviridae Infections (immunology, prevention & control, virology)
  • Species Specificity
  • Vaccination (methods)
  • Virus Replication (drug effects, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: